Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 27%
Buy 33%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia is in a strong financial position, with a strengthened balance sheet and a solid cash position. The company has a diverse customer base and offers a suite of solutions to address key challenges in healthcare delivery. By maintaining a strong focus on reinvesting in the core business and paying down debt, management is positioning the company for sustained growth. The recent launch of Provider Connect and PlanMatch, along with more bullish outlook on the Clips) can result in higher revenue and EBITDA estimates for FY27 and FY28. Overall, Phreesia is a dominant player in a growing digital health market and presents an attractive risk/reward profile for long-term investors.

Bears say

Phreesia is heavily dependent on a relatively new and unproven market in the healthcare industry, and if they are unable to successfully promote the benefits of their platform, growth may be limited. Additionally, the company must constantly adapt to rapidly changing industry standards and technology, and if they are unable to keep up with competitors, their services may become obsolete. The company's success also relies on increasing patient engagement and demand for their services, which could be impacted by economic conditions and shifting healthcare spending priorities. Furthermore, the company is at risk of integration challenges and faces competition from others with greater resources. Based on the company's recent financial performance and market conditions, the bear case scenario values the stock at $8 per share, and the base case scenario values it at $14 per share. Overall, there are significant risks facing Phreesia, and the analyst maintains a negative outlook on the stock.

Phreesia Inc (PHR) has been analyzed by 15 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 33% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 15 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of Sep 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.13, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.13, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.